LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 7.06 | 27.76 | 2 | 360 | 0.0056 | -0.5091 | MN20160318_Q01 | D13 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 7.06 | 27.76 | 569 | 360 | 1.5806 | 1.2636 | MN20160318_Q01 | D13 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 7.06 | 27.76 | 19 | 360 | 0.0528 | -0.0975 | MN20160318_Q01 | L09 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 7.06 | 27.76 | 769 | 360 | 2.1361 | 1.4558 | MN20160318_Q01 | L09 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 8.76 | 27.76 | 3 | 401 | 0.0075 | -0.4387 | MN20160318_Q01 | D13 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 8.76 | 27.76 | 589 | 401 | 1.4683 | 1.2097 | MN20160318_Q01 | D13 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 8.76 | 27.76 | 37 | 401 | 0.0922 | 0.0774 | MN20160318_Q01 | L09 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 8.76 | 27.76 | 804 | 401 | 2.0043 | 1.3955 | MN20160318_Q01 | L09 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 10.46 | 27.76 | 2 | 438 | 0.0046 | -0.4834 | MN20160318_Q01 | D13 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 10.46 | 27.76 | 621 | 438 | 1.4157 | 1.1825 | MN20160318_Q01 | D13 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 10.46 | 27.76 | 38 | 438 | 0.0866 | 0.0821 | MN20160318_Q01 | L09 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 10.46 | 27.76 | 836 | 438 | 1.9059 | 1.3516 | MN20160318_Q01 | L09 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 12.17 | 27.76 | 3 | 489 | 0.0061 | -0.4158 | MN20160318_Q01 | D13 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 12.17 | 27.76 | 655 | 489 | 1.3393 | 1.1463 | MN20160318_Q01 | D13 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 12.17 | 27.76 | 37 | 489 | 0.0757 | 0.0719 | MN20160318_Q01 | L09 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 12.17 | 27.76 | 831 | 489 | 1.6991 | 1.2733 | MN20160318_Q01 | L09 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 13.87 | 27.76 | 2 | 604 | 0.0033 | -0.4466 | MN20160318_Q01 | D13 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 13.87 | 27.76 | 645 | 604 | 1.0666 | 1.0292 | MN20160318_Q01 | D13 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 13.87 | 27.76 | 133 | 604 | 0.2199 | 0.4226 | MN20160318_Q01 | L09 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 13.87 | 27.76 | 866 | 604 | 1.4321 | 1.1683 | MN20160318_Q01 | L09 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 15.58 | 27.76 | 2 | 685 | 0.0029 | -0.4337 | MN20160318_Q01 | D13 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 15.58 | 27.76 | 647 | 685 | 0.9437 | 0.9751 | MN20160318_Q01 | D13 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 15.58 | 27.76 | 123 | 685 | 0.1794 | 0.3796 | MN20160318_Q01 | L09 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 15.58 | 27.76 | 887 | 685 | 1.2938 | 1.1145 | MN20160318_Q01 | L09 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 17.28 | 27.76 | 1 | 838 | 0.0012 | -0.4913 | MN20160318_Q01 | D13 |